Potential Health Risks of Gender-Affirming Hormone Therapy Raise Concerns for Adults and Children

A University of California Davis study reveals that estrogen-based gender-affirming hormone therapy may have contributed to thyroid cancer in three transgender military veterans. The patients, who were all born male and later identified as female, had a variety of cancer risk factors, but estrogen was the common link. Researchers suspect that estrogen may stimulate malignant cell growth in the thyroid, although the data is mixed, and further research is needed. The experts involved propose that transgender people be warned about the hazards of hormone therapy. This case emphasizes the need for additional research into the long-term implications of gender-affirming therapy.

Editor’s Note: These findings emphasize the dangers that hormone therapy can offer, for adults undergoing gender transition. If such side effects appear in fully grown adults, the long-term repercussions for children who are taking these drugs at a far younger age may be even more harmful and unpredictable. Children’s bodies are still developing, making them more susceptible to these potent treatments and medicines. The fact that parents who voice concern or hesitation regarding such medical interventions risk losing custody of their children heightens the moral and ethical concerns surrounding these procedures. [See also: Madness: Transgender ideology has enabled people to ‘identify’ as amputees, How Transgenderism Can Lead To Transhumanism, Royal College of Psychiatrists Cuts Ties with Stonewall Amid Transgender Care Concerns, Washington DC family loses custody of their autistic 16-year-old son after refusing to allow his transition to female]

Read Original Article